CLINICAL_TRIALS trial_result · 2015-04-15

Clinical Trial Update: Intranasal Oxytocin for the Treatment of Children and Adolescents With ASD (OXY) [Phase 2]

A Phase 2 clinical trial evaluating intranasal oxytocin for autism spectrum disorder in children and adolescents has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Evdokia Anagnostou | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED | Results posted: 2015-04-15